Nektar Therapeutics
NKTR
#4645
Rank
HK$16.17 B
Marketcap
HK$563.91
Share price
10.27%
Change (1 day)
610.47%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$33.12

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$33.15. In 2024 the company made an earnings per share (EPS) of -HK$27.43 an increase over its 2023 EPS that were of -HK$171.64.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$33.1220.73%
2024-HK$27.43-84.02%
2023-HK$171.64-25.89%
2022-HK$231.60-31.12%
2021-HK$336.2314.86%
2020-HK$292.73-1.19%
2019-HK$296.26-163.96%
2018HK$463.20-725.4%
2017-HK$74.06-42.73%
2016-HK$129.3283.33%
2015-HK$70.5439.53%
2014-HK$50.55-69.29%
2013-HK$164.59-6.67%
2012-HK$176.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.30-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.66-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.31-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$14.50-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.29-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$46.48-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.22-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland